On Feb. 13, FoxHollow Technologies (NASDAQ:FOXH) released fourth-quarter earnings for the period ended Dec. 31.
- Revenues increased by 6.3%, primarily because of the contribution from recently launched MiniHawk and a research collaboration with Merck (NYSE:MRK).
- The company reported a net loss of $4.9 million as a result of the inclusion of amortization and an increase in R&D and SG&A expenses.
- FoxHollow's balance sheet is in good shape, with $167 million cash and no debt.
- For fiscal 2007, the company expects high-single-digit revenue growth, with the top line in the range of $205 million-$215 million. Management expects the company to show a small profit on a GAAP basis.
- FoxHollow is a four-star stock in CAPS, the Fool's community-based stock-rating service.
(Figures in thousands, except per-share data)
Income Statement Highlights
|
Q4 2006 |
Q4 2005 |
Change | |
|---|---|---|---|
|
Sales |
$44,519 |
$41,878 |
6.3% |
|
Net Profit |
($4,851) |
($160) |
N/A |
|
EPS |
($0.18) |
($0.01) |
N/A |
|
Diluted Shares |
27,571 |
23,642 |
16.6% |
Get back to basics with a look at the income statement.
Margin Checkup
|
Q4 2006 |
Q4 2005 |
Change* | |
|---|---|---|---|
|
Gross Margin |
76.2% |
70.9% |
5.3 |
|
Operating Margin |
(12.7%) |
(1.7%) |
(11.0) |
|
Net Margin |
(10.9%) |
(0.4%) |
(10.5) |
Margins are the earnings engine. See how they work.
Balance Sheet Highlights
|
Assets |
Q4 2006 |
Q4 2005 |
Change |
|---|---|---|---|
|
Cash + ST Invest. |
$166,915 |
$59,915 |
178.6% |
|
Accounts Rec. |
$19,450 |
$21,831 |
(10.9%) |
|
Inventory |
$14,346 |
$15,607 |
(8.1%) |
|
Liabilities |
Q4 2006 |
Q4 2005 |
Change |
|---|---|---|---|
|
Accounts Payable |
$9,385 |
$7,072 |
32.7% |
|
Long-Term Debt |
$0 |
$0 |
0% |
Learn the ways of the balance sheet.
Cash Flow Highlights
A statement of cash flows was not provided.
Find out why Fools always follow the money.
Related Companies:
- ev3 (NASDAQ:EVVV)
- Boston Scientific (NYSE:BSX)
- Medtronic (NYSE:MDT)
- Spectranetics (NASDAQ:SPNC)
Related Foolishness:
- Taking FoxHollow's Pulse
- Dueling Fools: Merck Bull
- Big Week at Boston Scientific
- FoxHollow Taken to the Cleaners
Merck is a Motley Fool Income Investor pick.
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.
